Journal: Frontiers in Pharmacology
Article Title: LPM3770277, a Potent Novel CDK4/6 Degrader, Exerts Antitumor Effect Against Triple-Negative Breast Cancer
doi: 10.3389/fphar.2022.853993
Figure Lengend Snippet: Effects of Abemaciclib and LPM3770277 on the blood of nude mice. HFR%, High fluorescence intensity reticulocyte percentage; IRF, Immature reticulocyte fraction; LFR%, Low fluorescence intensity reticulocyte percentage; MRF%, Medium fluorescence intensity reticulocyte percentage; WBC, White blood cell; LYMPH#, Lymphocyte-count; NEUT#, Neutrophil count; EO%, Percentage of basophils; MONO%, Percentage of Monocyte; MONO#, Monocyte count. * p ˂ 0.05 vs. control, ** p ˂ 0.01 vs. control, One-way ANOVA with a post-hoc Bonferroni test was used for all the statistical analysis.
Article Snippet: Abemaciclib and Abemaciclib metabolite M2 were purchased from MedChemExpress (Monmouth Junction, NJ, United States, LY-2835219, LSN2839567).
Techniques: Fluorescence, Control